"Now, most people will have no symptoms, and the diagnosis is often picked up through a random blood test or a scan. But ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We've got lots ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

Seven patients were admitted to the hospital for the first time for treatment of liver disease, and 9 had had ... excessive salivation or local pain. Recently, Sandstead et al.

Most ICBs in England do not have effective referral pathways for diagnosing and managing liver disease, an analysis has shown ... many cases being identified too late and at a point when treatment ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults ... such as those with kidney or liver disease, he added.

The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults ... such as those with kidney or liver disease, he added. In a report last ...